The push for patient-centric trials is well-intentioned. No one wants to design research that patients can't access, don't understand, or feel uncomfortable joining. But that intention obscures a more accurate observation: when an IVD trial is ethical, clearly explained, and integrated into real care, most patients are willing to contribute — particularly when they're approached at the right time and treated with respect.
Centering trial design around hypothetical patient experience misses the point. Patients don't care about the minute details of a protocol. They care that their doctor can solve their problem, that their care isn't delayed, and that their visit isn't longer than it needs to be. Designing trials to minimize disruption to care inherently supports patient needs. The best way for research to align with those goals isn't to design around imagined patient feedback while treating trials as separate from clinical care — it's to make sure the study flows naturally within the visit itself.
If a study takes longer to explain than a typical clinical decision, it's already too complicated. The framework below is what that observation means for how we design IVD studies.
Patient centricity isn't the answer. Alignment with care is.
Patient experience is rarely the bottleneck. The bottleneck is whether the study fits the visit the physician already runs.
Patient-theater checklists — surveys about hypothetical discomfort, parallel research tracks, visit structures that treat the study as something separate from care — create the appearance of patient focus while making the study harder to run. The patient who is already in the room for a clinical visit does not need a second theater of research. They need a study that does not extend their visit, confuse their doctor, or ask them to come back for something that could have happened today.
When the protocol is written around how care actually happens, patient needs are met as a consequence. Consent is short because the visit is short. Participation feels familiar because it is familiar. The LAR pathway for cognitive impairment is operationalized because the confirmed-AD patient cannot enroll without it — not because a patient-centricity committee asked for it.
Before adding a “patient experience” requirement to a protocol, ask whether it reduces friction in the visit or adds a parallel track. If it adds a track, cut it. If it removes a step the site or patient would otherwise struggle with, keep it.
Simplicity drives results for every stakeholder.
When a trial feels like part of the standard of care, research is easier for clinicians, smoother for patients, and better for sponsors.
The benefits compound. Sponsors get higher enrollment, cleaner data, and fewer protocol deviations — which compresses timelines and reduces costly delay cycles. Patients get visits that feel familiar, consent that is straightforward, and participation that aligns with the care they already trust. Clinicians get minimal workflow disruption, clear communication, and studies that feel relevant to practice rather than a burden.
None of that comes from a patient-centricity slogan. It comes from designing the kit, the form, the consent, and the site conversation so that each one fits inside the visit the physician already knows how to run.
Test every study artifact against three readers: the sponsor who needs submission-grade data, the patient who has one visit, and the clinician who has ninety seconds. If an artifact fails any of the three, rewrite it before sites open.
Design for how care actually happens.
Simple does not mean easy. Making a trial feel easy requires more effort up front — targeting the right doctors, speaking their language, and removing friction at every touchpoint.
Getting providers on board is the first step. If a clinician doesn't believe in the study or can't immediately understand its purpose, they won't bring it into their practice. Target by specialty, patient population, and clinical behavior. Use the terms clinicians actually use. Respect their time — if the study takes longer to explain than a typical clinical decision, it is already too complicated. Make the value obvious: why the trial matters, how it moves the needle, and why their participation is meaningful.
Sustaining engagement means continuing to make the clinician's job as simple as possible — before, during, and after every patient visit. Pre-filled kit labels, step-by-step collection instructions, and embedded field prompts in case report forms eliminate ambiguity. Slide decks and training materials should be trimmed to only the necessities. Simplification is a discipline, and it requires up-front effort to make things intuitive at the point of use.
Simplicity does not stop at the clinic. Protocols should be IRB-friendly: highlight minimal-risk criteria and patient protections up front. When forms are self-evident and workflows are built around care as it is delivered, sponsors spend less time resolving queries and more time moving the study forward.
Across 300+ IVD engagements, the studies that enrolled cleanly were the ones that felt like an extension of the visit — not a second appointment bolted onto it. The studies that stalled were often the ones that optimized for a patient-experience narrative while ignoring physician workflow.
A thirty-minute meeting with a clinician should be the result of weeks of planning to fine-tune the message. Spend that time before the first outreach, not after the first refusal.
The better the design, the easier the path.
The better the design, the easier it is to get a diagnostic to market. That requires deep experience, thoughtful planning, and a team that knows how to deliver complex trials with a clear approach that benefits everyone involved — an experienced, IVD-specific CRO partner.
They rule out patient-theater checklists as a substitute for operational design. They rule out treating the study as separate from care. They rule out asking physicians to absorb complexity the sponsor should have removed upstream.
RDI has supported hundreds of trials. The domain expertise that comes with that body of work is what makes alignment with the standard of care a craft rather than a slogan. When it's IVD, rely on RDI.